Pichapong Tunsupon1, M Jeffery Mador2,3. 1. Division of Pulmonary, Critical Care and Sleep Medicine Department of Medicine, University of Florida, 1600 SW Archer Road, M415, PO BOX 100225, Gainesville, FL, 32610, USA. pichapong.tunsupon@medicine.ufl.edu. 2. Division of Pulmonary, Critical Care and Sleep Medicine Department of Medicine, University at Buffalo State University of New York, 3495 Bailey Avenue, Buffalo, NY, 14215, USA. 3. Western New York Veterans Administration Healthcare System, 3495 Bailey Avenue, Buffalo, NY, 14215, USA.
Abstract
INTRODUCTION: Alterations in body composition are commonly present in chronic obstructive pulmonary disease (COPD). The hypothesis of this study is that COPD patients would achieve clinical benefits after pulmonary rehabilitation (PR) independent of muscle mass depletion or body weight. METHODS: We conducted a retrospective cohort study using single-frequency bioelectrical impedance analysis (BIA) for assessment of fat-free mass (FFM) depletion (muscle depletion). Patients were stratified into three categories based on (1) obesity BMI ≥ 30 kg/m2, (2) non-obesity BMI < 30 kg/m2, and (3) combined cachexia (BMI < 21 kg/m2 and FFM index < 16 kg/m2) and muscle atrophy (BMI ≥ 21 kg/m2 and FFMI < 16 kg/m2). PR outcomes were defined as the improvement in exercise capacity (maximal exercise capacity, 6-min walk, constant workload cycle exercise duration) and quality of life determined by Chronic Respiratory Questionnaire after PR. RESULTS: We studied 72 patients with available FFM measured by BIA. Patients were predominantly elderly man (N = 71; 98%), with a mean age of 72 years with COPD GOLD stage I-IV. The groups were balanced in terms of age, comorbidities, baseline FEV1, exercise capacity, and quality of life. The absolute changes in patients with muscle depletion or obesity compared to those without muscle depletion or obesity were not statistically different as was the percentage of patients reaching the minimal clinically important difference (MCID) after PR. CONCLUSION: A comprehensive PR program in COPD patients improved exercise tolerance and quality of life independent of muscle mass depletion or obesity. Similarly, muscle depletion or obesity had no effect on the percentage of patients achieving the MCID for measures of quality of life and exercise tolerance after PR.
INTRODUCTION: Alterations in body composition are commonly present in chronic obstructive pulmonary disease (COPD). The hypothesis of this study is that COPDpatients would achieve clinical benefits after pulmonary rehabilitation (PR) independent of muscle mass depletion or body weight. METHODS: We conducted a retrospective cohort study using single-frequency bioelectrical impedance analysis (BIA) for assessment of fat-free mass (FFM) depletion (muscle depletion). Patients were stratified into three categories based on (1) obesity BMI ≥ 30 kg/m2, (2) non-obesity BMI < 30 kg/m2, and (3) combined cachexia (BMI < 21 kg/m2 and FFM index < 16 kg/m2) and muscle atrophy (BMI ≥ 21 kg/m2 and FFMI < 16 kg/m2). PR outcomes were defined as the improvement in exercise capacity (maximal exercise capacity, 6-min walk, constant workload cycle exercise duration) and quality of life determined by Chronic Respiratory Questionnaire after PR. RESULTS: We studied 72 patients with available FFM measured by BIA. Patients were predominantly elderly man (N = 71; 98%), with a mean age of 72 years with COPD GOLD stage I-IV. The groups were balanced in terms of age, comorbidities, baseline FEV1, exercise capacity, and quality of life. The absolute changes in patients with muscle depletion or obesity compared to those without muscle depletion or obesity were not statistically different as was the percentage of patients reaching the minimal clinically important difference (MCID) after PR. CONCLUSION: A comprehensive PR program in COPDpatients improved exercise tolerance and quality of life independent of muscle mass depletion or obesity. Similarly, muscle depletion or obesity had no effect on the percentage of patients achieving the MCID for measures of quality of life and exercise tolerance after PR.
Entities:
Keywords:
Bioelectrical impedance analysis; Body composition; Chronic obstructive pulmonary disease; Muscle mass depletion; Pulmonary rehabilitation
Authors: Andrew L Ries; Gerene S Bauldoff; Brian W Carlin; Richard Casaburi; Charles F Emery; Donald A Mahler; Barry Make; Carolyn L Rochester; Richard Zuwallack; Carla Herrerias Journal: Chest Date: 2007-05 Impact factor: 9.410
Authors: Annemie M W J Schols; Roelinka Broekhuizen; Clarie A Weling-Scheepers; Emiel F Wouters Journal: Am J Clin Nutr Date: 2005-07 Impact factor: 7.045
Authors: Danilo C Berton; Leonardo Silveira; Cassia C Da Costa; Rafael Machado De Souza; Claudia D Winter; Paulo José Zimermann Teixeira Journal: Arch Phys Med Rehabil Date: 2013-02-14 Impact factor: 3.966
Authors: Paul L Enright; Mary Ann McBurnie; Vera Bittner; Russell P Tracy; Robert McNamara; Alice Arnold; Anne B Newman Journal: Chest Date: 2003-02 Impact factor: 9.410
Authors: Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni Journal: Age Ageing Date: 2010-04-13 Impact factor: 10.668
Authors: Harry R Gosker; Mariëlle P K J Engelen; Henk van Mameren; Paul J van Dijk; Ger J van der Vusse; Emiel F M Wouters; Annemie M W J Schols Journal: Am J Clin Nutr Date: 2002-07 Impact factor: 7.045
Authors: L Laviolette; J Bourbeau; S Bernard; Y Lacasse; V Pepin; M-J Breton; M Baltzan; M Rouleau; F Maltais Journal: Thorax Date: 2007-09-27 Impact factor: 9.139
Authors: Celalettin Korkmaz; Soner Demirbas; Hulya Vatansev; Elif Yildirim; Turgut Teke; Adil Zamani Journal: J Int Med Res Date: 2020-04 Impact factor: 1.671